Here’s what you should know:
1. HCA and KKR are one of three groups competing to acquire Envision.
2. The Post reports KKR secured approximately 7.25 times EBITDA in financing, which would amount to a bid in the high-$40 range for the company. Envision shareholders previously said they’d accept a bid in the mid-$40 range.
3. If HCA acquires Envision and subsidiary AmSurg, HCA would almost triple its ASC-related holdings. The combined companies would have 354 ASCs. HCA would add approximately $1.3 billion in revenue as a result.
4. HCA would also expand its presence into 16 additional states and Washington, D.C.
5. After low third-quarter 2017 earnings, Envision began an internal review to “enhance shareholder value.” Envision’s board said a company sale was being considered.
6. The Post believes activist investors are weighing a proxy fight to gain control of the board, if they are not satisfied with the sale process.
More articles on transactions/valuations:
7 things for ASC leaders to know for Thursday — June 7, 2018
How ASCs are changing as CMS adds procedures, mandates quality reporting
Pain physician faces insurance fraud, perjury after referring workers comp cases to ASC, lab he owned: 4 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
